Header Logo

Connection

ERIC CHANG to Brain Neoplasms

Back to Details
This is a "connection" page, showing publications ERIC CHANG has written about Brain Neoplasms.
ERIC CHANG
Connection Strength
1.860
Brain Neoplasms
  1. Executive summary of American Radium Society's appropriate use criteria for the postoperative management of lower grade gliomas. Radiother Oncol. 2022 05; 170:79-88.
    View in: PubMed
    Score: 0.377
  2. Management of complications from brain metastasis treatment: a narrative review. Chin Clin Oncol. 2022 Apr; 11(2):11.
    View in: PubMed
    Score: 0.366
  3. Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis. Int J Radiat Oncol Biol Phys. 2015 Mar 15; 91(4):710-7.
    View in: PubMed
    Score: 0.231
  4. Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma. Int J Radiat Oncol Biol Phys. 2007 May 01; 68(1):144-50.
    View in: PubMed
    Score: 0.132
  5. An update to the American Radium Society's appropriate use criteria of lower grade gliomas: Integration of IDH inhibitors. Radiother Oncol. 2025 Jan; 202:110640.
    View in: PubMed
    Score: 0.113
  6. Emergent radiotherapy for brain and leptomeningeal metastases: a narrative review. Ann Palliat Med. 2023 Nov; 12(6):1405-1419.
    View in: PubMed
    Score: 0.103
  7. Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors. Int J Radiat Oncol Biol Phys. 2003 Jun 01; 56(2):519-28.
    View in: PubMed
    Score: 0.102
  8. Assembling the brain trust: the multidisciplinary imperative in neuro-oncology. Nat Rev Clin Oncol. 2019 08; 16(8):521-522.
    View in: PubMed
    Score: 0.078
  9. Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma. Neuro Oncol. 2015 Feb; 17(2):266-73.
    View in: PubMed
    Score: 0.056
  10. Stereotactic radiosurgery for multiple brain metastases. Expert Rev Anticancer Ther. 2014 Oct; 14(10):1153-72.
    View in: PubMed
    Score: 0.055
  11. The impact of tyrosine kinase inhibitors on the multimodality treatment of brain metastases from renal cell carcinoma. Am J Clin Oncol. 2013 Dec; 36(6):620-4.
    View in: PubMed
    Score: 0.053
  12. Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain? Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67(4):1135-44.
    View in: PubMed
    Score: 0.033
  13. Focal and craniospinal irradiation for patients with intracranial germinoma and patterns of failure. Cancer. 2006 Nov 01; 107(9):2228-36.
    View in: PubMed
    Score: 0.032
  14. Case-control study of stereotactic radiosurgery for recurrent glioblastoma multiforme. J Neurosurg. 2005 Aug; 103(2):210-7.
    View in: PubMed
    Score: 0.030
  15. YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma. Clin Cancer Res. 2005 May 01; 11(9):3326-34.
    View in: PubMed
    Score: 0.029
  16. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys. 2004 Jul 15; 59(4):1097-106.
    View in: PubMed
    Score: 0.028
  17. Radiotherapy after surgery for benign cerebral meningioma. Radiother Oncol. 2004 Apr; 71(1):85-90.
    View in: PubMed
    Score: 0.027
  18. A single-field integrated boost treatment planning technique for spot scanning proton therapy. Radiat Oncol. 2014 Sep 11; 9:202.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.